Here’s whether Avanos Medical, Inc. (AVNS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+12.43% over 10 days); RSI 44 — healthy momentum range; strong 1-year return of +97.2%; 3-month momentum positive (+80.4%). Concerns: declining volume on rally — weak conviction (0.54x 30d avg). Currently 1.2% off its 52-week high. Score: +6/7.
AVNS is in a confirmed uptrend, trading above both its 50-day ($20.11) and 200-day ($14.14) moving averages. An RSI of 44.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +97.2% compares to +27.9% for SPY (beat the market by 69.3%).
$10,000 invested 1 year ago→ $19,720 today
vs. S&P 500 (SPY) — same period beat market by 69.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($14.14)
✓Above 50-day MA ($20.11)
✓RSI(14) neutral zone (30–70) — currently 44.2
✓Positive return (+97.2%)
✓Within 10% of period high (−1.2%)
Period Range $24.61
$9.30$24.91
RSI (14) 44.2
0 · OversoldOverbought · 100
Key Metrics
Price$24.61
Period Return+97.2%
Period High$24.91
Period Low$9.30
Drawdown−1.2%
MA-50$20.11
MA-200$14.14
RSI (14)44.2
Avg Volume (30d)2.2M
vs. SPYbeat by 69.3%
Return Rank#223 of 1236
Trend Signals
Price is above the 200-day moving average ($14.14)